Latest filing published 22 Dec 2021 for 南微医学, €104k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -46.7%Entry CN¥159.13 · Close at T+365 CN¥84.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
芮晨为: trading record in brief
芮晨为 (senior executive) discloses dealings in 南微医学 to SSE / SZSE (CSRC). Between 21 May 2021 and 22 December 2021, the trades on record add up to 4 filings.
Market trades split into 1 purchase (€104k) and 3 sales (€3.3M). Taken together, the sales exceed the purchases by €3.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 22 December 2021, reports an open-market purchase of €104k in 南微医学. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 芮晨为
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,400 shares3.0% of flowA股XSHGSSE:173000005457335900Canonical exit: 22 Mar 2022 (T+90)
- 40,000 shares41.2% of flowA股XSHGSSE:173000004436548100
- 51,500 shares50.1% of flowA股XSHGSSE:173000004441223600
- 6,000 shares5.7% of flowA股XSHGSSE:173000004432459700
4 of 4 declarations